Episode 10 – Interview with Dr. Sholzberg on COVID coagulopathy

Welcome back Rounds Table Listeners!

This week we interviewed Dr. Michelle Sholzberg to discuss coagulopathy associated with COVID-19.

Dr. Sholzberg is a clinical hematologist with a focus on bleeding and is the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital in Toronto, Ontario, Canada. She is also the Co-Director of the Hematology-Oncology Clinical Research Group and of the Hematology-Immunology Translational Research Theme.

She is Principal Investigator on the RAPID-COVID COAG Study which is randomizing patients hospitalized with COVID-19 who have an elevated d-dimer to review low dose versus therapeutic dose anti-coagulation.

Learn more about the study here: @COVIDtrialsON or by emailing Dr. Sholzberg (Michelle.Sholzberg@unityhealth.to).

Questions? Comments? Feedback? We’d love to hear from you. @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

1 Comment
  • Dr. Maha Othman says:

    Excellent discussion and synopsis on COVID coagulopathy + introduction to RAPID COVID RCT. All the best.


Michael Fralick

Co-director of the Rounds Table

Michael Fralick is a general internist at Mount Sinai Hospital in Toronto. He completed a Master of Science in Clinical Epidemiology at Harvard University, including a Research Fellowship in Health Policy at the Program On Regulation Therapeutics and Law (PORTAL). His PhD focused on the intersection between machine learning and pharmacoepidemiology.

John Fralick


John Fralick is a general internist at Foothills Medical Centre in Calgary. He completed a Master of Science in Epidemiology at Queen’s University. He completed medical school at the University of Calgary and did his internal medicine training at the University of Toronto.

Michelle Sholzberg